LEWISVILLE, Texas--( BUSINESS WIRE )--Orthofix International N.V. (NASDAQ:OFIX) today announced the appointment of Ronald A. Matricaria as a Director and Chairman of the Board. Mr. Matricaria replaces Kathleen ("Kathy") Regan, who has served as Interim Chair since January. Ms. Regan will continue to serve as an independent director for the Company and Chair of the Nominating and Governance Committee. "On behalf of the Board of Directors, I am delighted to welcome Ron as Chairman," said Kathy Regan. "His wealth of experience as both an executive and director in the medical device industry will be instrumental in successfully building the company to the next level. I see this significant event as an example of the efforts being made to position the Company for long-term stability and growth." Mr. Matricaria has more than 35 years of medical device and pharmaceutical experience at St. Jude Medical, Inc. and Eli Lilly and Company.